Comments by the German Society for Cytology (DGZ) on Primary Screening for Human Papilloma Viruses (HPV) within the Framework of Gynaecological Early Cancer Detection - August 2003;Stellungnahme der Deutschen Gesellschaft für Zytologie (DGZ) zum Primären Screening auf Humane Papillomviren (HPV) im Rahmen der Gynäkologischen Krebsfrüherkennung - August 2003

Geburtshilfe und Frauenheilkunde

Volumn 64, Issue 1, 2004, Pages 23-24

  Nauth, H F ^a  

^a NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CYTODIAGNOSIS; CANCER SCREENING; CYTOPATHOLOGY; EARLY DIAGNOSIS; FEMALE; GERMANY; GYNECOLOGIC CANCER; HUMAN; HUMAN CELL; MEDICAL SOCIETY; NOTE; PRACTICE GUIDELINE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; WART VIRUS;

EID: 1642430689     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-44692     Document Type: Note

References (11)

1. Council Recommendation. Commission of the European Communities. Proposal for a Council Recommendation on Cancer Screening. 2003/0093 (CNS). Brussels, 5th of May, 2003
2. Davey DD, Armenti CA. HPV primary screening for cervical cancer: More pain than protection. Diagn Cytopathol 2000; 22: 333-335
3. Herrington CS. Does HPV testing have a role in primary cervical screening? Cytopathology 2001; 12: 71-74
4. Petry KU, Menton S, Menton M et al, Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: Results for 8466 patients. Br J Cancer 2003: 88: 1570-1577
5. Schenck U. Zytologisches Vorsorgeprogramm - Durch neue Methoden ernsthaft herausgefordert? Geburtsh Frauenheilk 2000; 60: M125-127
6. Schneider A, Scheungraber C, Hoyer H, Dürst M. Früherkennung des Zervixkarzinoms: Zytologie oder HPV-Test? Gynäkologe 2002; 35: 181-192
7. Schneider V. Zervixabstrich noch zeitgemäβ? Frauenheilkunde plus 2001; 1: 30-33
8. Syrjänen K, Syrjänen S. Papillomavirus Infections in Human Pathology. New York: Wiley, 2000: 1-615
9. Tempfer C, Leodolter S, Kainz C. Aktuelle Wertigkeit der HPV-Testung in der klinischen Praxis. Geburtsh Frauenheilk 2002; 62: 543-549
10. Tidy J. Forgotten implications of HPV positivity for the majority of females: A clinical perspective. Cytopathology 2002; 13: 263-266
11. U. S. Preventive Services Task Force, Screening for Cervical Cancer. AHRQ Publication No. 03 - 515 A; January 2003. Agency for Healthcare Research and Quality, Rockville, MD. http:www.ahrq.gov/clinic/3rduspstf/cervicalcan/cervcanrr.htm